drugset / Trial / NCT07035457
A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the relative bioavailability of vicadrostat and empagliflozin when administered in combination or individually.
Timeline
- Start
- 2025-07-02
- Primary completion
- 2025-08-07
- Completion
- 2025-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | — | — |
| Subject | Vicadrostat | Small molecule | — | — |
Indications
No indication recorded.